MedTrace Logo

KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer

NCT02337465 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-23

Study results available
· View outcomes & findings →

Summary

This clinical trial studies if kilo-voltage cone beam computed tomography (KV-CBCT) and ultrasound imaging works in guiding radiation therapy in patients with prostate, liver, or pancreatic cancer. Computer systems, such as KV-CBCT and ultrasound imaging, allow doctors to create a 3-dimensional picture of the tumor may help in planning radiation therapy and may result in more tumor cells being killed.

Conditions

  • Adult Liver Carcinoma
  • Malignant Pancreatic Neoplasm
  • Prostate Carcinoma

Interventions

DEVICE

Cone-Beam Computed Tomography

Undergo kilo-voltage cone beam computed tomography

RADIATION

3-Dimensional Ultrasound-Guided Radiation Therapy

Undergo ultrasound-guided radiation therapy

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Ping Xia, PhD · Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

  • Kevin Stephans, MD · Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-22
Primary Completion
2019-12-14
Completion
2019-12-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02337465 on ClinicalTrials.gov